NCT00480194View on ClinicalTrials.gov

Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000 (XY-005-IM)

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Common Cold
Interventions
DRUG

xylometazoline hydrochloride and ipratropium bromide (ZyComb)

Common cold in a real-life OTC setting

Sponsors

Lead Sponsor

Nycomed
All Listed Sponsors
lead

Nycomed

INDUSTRY